Delhi reports 96 new COVID-19 cases, lowest in over 9 months

The last time Delhi reported less than 100 fresh infections within 24 hours was on April 30. Since then, the number of daily new cases being reported by Delhi has always been above 100 with the number touching thousands on several days.

Moneycontrol News

January 27, 2021 / 07:45 PM IST

On April 30, Delhi had reported 76 new COVID-19 cases and 59 deaths.

Delhi reported 96 new COVID-19 cases on January 27 - the lowest single-day count in over nine months.

A total of nine persons died of the coronavirus disease in the past 24 hours, taking Delhi's total COVID-19 death toll to 10,829. The total number of coronavirus cases in the National Capital now stands at 6,34,325.

For live updates on coronavirus, click here

One must note that the low case count was reported on the back of only about 30,000 coronavirus tests that were conducted on Republic Day. However, just as in the rest of the country, the city’s overall positivity rate has also declined recently.

At one time, during the peak of its third wave, Delhi’s COVID-19 positivity rate had shot to nearly 15 percent with more than 8,000 fresh cases being reported daily. That has now come down to just 0.32 percent.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show